Alcon Inc.
$77.24
▼
-0.75%
2026-04-22 10:12:13
www.alcon.com
NYQ: ALC
Explore Alcon Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$30.37 B
Current Price
$77.24
52W High / Low
$81.92 / $56.44
Stock P/E
—
Book Value
$45.2
Dividend Yield
0.45%
ROCE
4.77%
ROE
4.5%
Face Value
—
EPS
—
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
25,942
Beta
0.74
Debt / Equity
23.81
Current Ratio
2.12
Quick Ratio
1.33
Forward P/E
19.89
Price / Sales
3.75
Enterprise Value
$41.66 B
EV / EBITDA
17.87
EV / Revenue
4
Rating
Buy
Target Price
$95.31
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 2. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
| 3. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 4. | Repligen Corporation | $130.14 | 150.55 | $7.4 B | — | 1.48% | 2.4% | $175.77 / $109.66 | $37.39 |
| 5. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 6. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
| 7. | Sanara MedTech Inc. | $20.62 | — | $190.4 M | — | 16.84% | -1.75% | $35.95 / $16.05 | $0.66 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.72 B | 2.61 B | 2.6 B | 2.47 B | 2.5 B | — |
| Operating Profit | 313 M | 332 M | 247 M | 468 M | 395 M | — |
| Net Profit | 217 M | 237 M | 176 M | 350 M | 284 M | — |
| EPS in Rs | 0.45 | 0.49 | 0.36 | 0.72 | 0.58 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 10.4 B | 9.91 B | 9.46 B | 8.72 B |
| Operating Profit | 1.36 B | 1.41 B | 1.04 B | 672 M |
| Net Profit | 980 M | 1.02 B | 974 M | 335 M |
| EPS in Rs | 2.01 | 2.09 | 2 | 0.69 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 31.55 B | 30.35 B | 29.61 B | 29.16 B |
| Total Liabilities | 31.55 B | 30.35 B | 8.99 B | 9.49 B |
| Equity | 22.01 B | 21.53 B | 20.62 B | 19.68 B |
| Current Assets | 6.45 B | 6.31 B | 5.65 B | 5.19 B |
| Current Liabilities | 3.05 B | 2.28 B | 2.4 B | 2.74 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.27 B | 2.08 B | 1.39 B | 1.22 B |
| Investing CF | -1.34 B | -1.17 B | -1.09 B | -1.86 B |
| Financing CF | -1.12 B | -322 M | -211 M | -8 M |
| Free CF | 1.61 B | 1.41 B | 537 M | 472 M |
| Capex | -663 M | -670 M | -851 M | -745 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.82% | 8.47% | — | — |
| Earnings Growth % | 4.52% | 190.75% | — | — |
| Profit Margin % | 10.27% | 10.3% | 3.84% | — |
| Operating Margin % | 14.26% | 10.99% | 7.71% | — |
| Gross Margin % | 55.61% | 55.49% | 54.47% | — |
| EBITDA Margin % | 27% | 23.71% | 19.73% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-05-13 | $0.331 |
| 2024-05-14 | $0.264 |
| 2023-05-10 | $0.236 |
| 2022-05-03 | $0.205 |
| 2021-05-04 | $0.11 |
Stock Splits
No stock split history available.